miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance

Qu, Shuping; Zhang, Xiaobing; Wu, Yue; Li, HengYu; Zhai, Jian; Wu, Dong

doi:10.7150/jca.52395



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2021; 12(5):1483-1492. doi:10.7150/jca.52395 This issue Cite

Research Paper

miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance

Shuping Qu^1,#, Xiaobing Zhang^1,#, Yue Wu^1,#, HengYu Li², Jian Zhai^1,✉, Dong Wu^1,✉

1. Department of Hepatic Surgery, Third Affiliated Hospital of Second Military Medical University, Shanghai, 200438, China.
2. Department of General surgery, First Affiliated Hospital of Second Military Medical University, Shanghai, 200433, China.
^#These authors contributed equally to this work.

Citation:

Qu S, Zhang X, Wu Y, Li H, Zhai J, Wu D. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance. J Cancer 2021; 12(5):1483-1492. doi:10.7150/jca.52395. https://www.jcancer.org/v12p1483.htm

Other styles

Abstract

Increasing evidence shows that liver tumor-initiating cells (T-ICs) closely associated with the progression, metastasis, recurrence and chemo-resistance of hepatocellular carcinoma (HCC). However, the underlying mechanism for the propagation of liver T-ICs remains unclear. Here we show that miR-361-3p is upregulated in liver T-ICs. Knockdown of miR-361-3p impairs the self-renewal and tumorigenicity liver T-ICs. Conversely, forced miR-361-3p expression enhances the self-renewal and tumorigenicity liver T-ICs. Mechanistically, miR-361-3p directly targets SOX1 via binding its 3'-UTR in liver T-ICs. Moreover, miR-361-3p knockdown hepatoma cells are more sensitive to cisplatin or sorafenib treatment. Clinical cohort analysis demonstrates that miR-361-3p low HCC patients are benefited from TACE (transcatheter arterial chemoembolization) or sorafenib treatment. In conclusion, our findings revealed the crucial role of the miR-361-3p in liver T-IC expansion and TACE or sorafenib response, rendering miR-361-3p an optimal target for the prevention and intervention in HCC.

Keywords: Tumor-initiating cells, hepatocellular carcinoma, miR-361-3p, SOX1, cisplatin, sorafenib

Citation styles

APA

Qu, S., Zhang, X., Wu, Y., Li, H., Zhai, J., Wu, D. (2021). miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance. Journal of Cancer, 12(5), 1483-1492. https://doi.org/10.7150/jca.52395.

ACS

Qu, S.; Zhang, X.; Wu, Y.; Li, H.; Zhai, J.; Wu, D. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance. J. Cancer 2021, 12 (5), 1483-1492. DOI: 10.7150/jca.52395.

NLM

CSE

Qu S, Zhang X, Wu Y, Li H, Zhai J, Wu D. 2021. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance. J Cancer. 12(5):1483-1492.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.